Sacubitrilat
![]() | |
Clinical data | |
---|---|
ATC code | none |
Identifiers | |
| |
Synonyms | LBQ657 |
CAS Number | 149709-44-4 |
PubChem (CID) | 10430040 |
ChemSpider | 8605468 |
UNII | SPI5PBF81S |
ChEMBL | CHEMBL417007 |
PDB ligand ID | 6LD (PDBe, RCSB PDB) |
Chemical and physical data | |
Formula | C22H25NO5 |
Molar mass | 383.44 g·mol−1 |
3D model (Jmol) | Interactive image |
| |
|
Sacubitrilat (INN; or LBQ657) is the active metabolite of the antihypertensive drug sacubitril,[1] which is used in the treatment of heart failure.[2]
References
- ↑ Solomon, SD. "HFpEF in the Future: New Diagnostic Techniques and Treatments in the Pipeline". Boston. p. 48. Retrieved 2012-01-26.
- ↑ "FDA approves new drug to treat heart failure". Food and Drug Administration. 7 July 2015.
This article is issued from Wikipedia - version of the 6/15/2016. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.